Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 4.01, 9.01 · 8-K

Cell Source, Inc.

CLCSOTCEQUITYCurrent

Changes in Registrant's Certifying Accountant

Item 4.01 Changes in Registrant’s Certifying Accountant. CBIZ CPAs P.C. (“CBIZ CPAs”) acquired the attest business of Marcum LLP (“Marcum”), effective November 1, 2024. As a result of this transaction, on June 26, 2025, Marcum resigned as the independent registered public accounting firm of Cell Source, Inc.…

Filed Jun 27, 2025Accepted Jun 27, 2025, 11:50 AM EDTCIK 1569340Accession 0001641172-25-016833
Share

Company context

Current securities

Recent company filings

  1. 10-Q filingMay 14, 2026
  2. 10-K filingApr 7, 2026
  3. 15-12G filingJul 16, 2025
  4. NT 10-K filingMar 28, 2025
  5. 10-Q filingNov 14, 2024

Disclosure sections

Items 4.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 4.01Item 4.01 - Changes in Certifying Accountant
Item 4.01 Changes in Registrant’s Certifying Accountant. CBIZ CPAs P.C. (“CBIZ CPAs”) acquired the attest business of Marcum LLP (“Marcum”), effective November 1, 2024. As a result of this transaction, on June 26, 2025, Marcum resigned as the independent registered public accounting firm of Cell Source, Inc. (the “Company”) and, with the approval of the Audit Committee of the Company’s Board of Directors, CBIZ CPAs was engaged as the Company’s independent registered public accounting firm for the year ended December 31, 2024. The audit reports of Marcum on the Company’s consolidated financial statements for the fiscal years ended December 31, 2023 and 2022 contained no adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles, except that the report for the fiscal years ended December 31, 2023 and 2022 included an explanatory paragraph relating to substantial doubt about the Company’s ability to continue as a going concern. Marcum did not provide an audit report on the Company’s consolidated financial statement for the year ended December 31, 2024. During the fiscal years ended December 31, 2024, 2023, 2022 and the subsequent interim period through June 26, 2025, there were (i) no disagreements (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) with Marcum on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which disagreements if not resolved to the satisfaction of Marcum would have caused them to make reference thereto in connection with their reports on the financial statements for such years and (ii) no reportable events (as described in Item 304(a)(1)(v) of Regulation S-K). During the fiscal years ended December 31, 2024, 2023 and 2022, and through June 26, 2025, neither the Company nor anyone on its behalf consulted with CBIZ CPAs regarding either: (i) the application of accounting principles to a specific transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, and neither a written report nor oral advice was provided to the Company that CBIZ CPAs concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or (ii) any matter that was either the subject of a disagreement (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) or any reportable event (as described in Item 304(a)(1)(v) of Regulation S-K). The Company provided Marcum with a copy of the above statements and requested that Marcum furnish it with a letter addressed to the U.S. Securities and Exchange Commission stating whether or not it agrees with the above statements. A copy of such letter, dated June 27, 2025, is filed as Exhibit 16.1 to this Current Report on Form 8-K. ITEM 9.01. FINANCIAL STATEMENT AND EXHIBITS. (d) Exhibits. Exhibit Description No. ────────────────────────────────────────────────────────────────────────────────────────────────────────── 16.1 Letter from Marcum LLP, dated June 27, 2025, addressed to the Securities and Exchange Commission 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.